Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
InChi: InChI=1S/C18H24N2OS/c1-17(2
It was approved by the United States Food and Drug Administration (FDA) in November 2005
In animal models of Parkinson's disease
m-PEG7-Hydrazide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs
Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride ole triol InChi: InChI=1S/C18H24N2OS/c1-17(2Thalidomide NH amido PEG4 C2 NH2 hydrochloride is a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Product information Molecular Weight: 586. 03 Formula: C25H36ClN5O9 Chemical Name: N (14 amino 3,6,9,12 tetraoxatetradecan 1 yl) 2 {[2 (2,6 dioxopiperidin 3 yl) 1,3 dioxo 2,3 dihydro 1H isoindol 4 yl]amino}acetamide; chlorohydrogen Smiles: Cl.
US$ 1140.00
US$ 1080.00